17:11 EDT Summit Therapeutics (SMMT) files to sell 26.68M shares of common stock for holders
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMT:
- Summit Therapeutics’ Phase 3 Study on Ivonescimab: A Potential Game-Changer for NSCLC Treatment
- Summit Therapeutics’ Phase 3 Study on Ivonescimab: A Potential Game-Changer in NSCLC Treatment
- Biotech Alert: Searches spiking for these stocks today
- Buy Rating for Summit Therapeutics Driven by Promising HARMONi-6 Trial Results and Improved Safety Profile
- Summit Therapeutics jumps after CAO buys $500,000 shares